Rock Springs Capital Management LP Aclaris Therapeutics, Inc. Transaction History
Rock Springs Capital Management LP
- $3.83 Billion
- Q1 2024
A detailed history of Rock Springs Capital Management LP transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 2,753,495 shares of ACRS stock, worth $2.84 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
2,753,495
Previous 2,998,495
8.17%
Holding current value
$2.84 Million
Previous $3.15 Million
8.45%
% of portfolio
0.09%
Previous 0.08%
Shares
24 transactions
Others Institutions Holding ACRS
# of Institutions
102Shares Held
53.5MCall Options Held
51KPut Options Held
31.6K-
Bml Capital Management, LLC Zionsville, IN9.4MShares$9.68 Million7.8% of portfolio
-
Black Rock Inc. New York, NY5.2MShares$5.36 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.93MShares$5.08 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.28MShares$3.38 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.27MShares$3.37 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $68.7M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...